Skip to Content

Fluzone Quadrivalent Dosage

Generic name: INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 15ug in 0.5mL, INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 15ug in 0.5mL, INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) 15ug in 0.5mL, INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) 15ug in 0.5mL
Dosage form: suspension for intramuscular injection

See also:

Medically reviewed by Drugs.com. Last updated on July 2, 2020.

For intramuscular use only

Dose and Schedule

The dose and schedule for Fluzone Quadrivalent are presented in Table 1.

Prior to vaccination, always refer to the current Advisory Committee on Immunization Practices annual recommendations on prevention and control of influenza vaccines.

Table 1: Dose and Schedule for Fluzone Quadrivalent
Age Vaccination Status Dose Schedule
"-" Indicates information is not applicable
*
The schedule can be completed as two 0.25-mL doses ≥4 weeks apart, two 0.5-mL doses ≥4 weeks apart, or any combination of 2 doses (either 0.25 mL or 0.5 mL) administered ≥4 weeks apart
To determine if 1 or 2 doses are required, refer to Advisory Committee on Immunization Practices annual recommendations on prevention and control of influenza with vaccines
6 months through 35 months Not previously vaccinated with influenza vaccine or unknown vaccination history Two doses, either 0.25 mL or 0.5 mL* Administer at least 4 weeks apart
Previously vaccinated with influenza vaccine One or two doses, either 0.25 mL or 0.5 mL* If two doses, administer at least 4 weeks apart
36 months through 8 years Not previously vaccinated with influenza vaccine or unknown vaccination history Two 0.5 mL doses Administer at least 4 weeks apart
Previously vaccinated with influenza vaccine One or two 0.5 mL doses If two doses, administer at least 4 weeks apart
9 years and older - One 0.5 mL dose -

Administration

Parenteral drug products should be inspected visually for particulate matter and/or discoloration prior to administration, whenever solution and container permit. If any of these defects or conditions exist, Fluzone Quadrivalent should not be administered.

Before administering a dose of vaccine, shake the prefilled syringe or vial. Withdraw one dose of vaccine from the single-dose vial using a sterile needle and syringe. Discard unused portion. Use a separate sterile needle and syringe for each dose withdrawn from the multi-dose vial.

The preferred sites for intramuscular injection are the anterolateral aspect of the thigh in infants 6 months through 11 months of age, the anterolateral aspect of the thigh (or the deltoid muscle if muscle mass is adequate) in persons 12 months through 35 months of age, or the deltoid muscle in persons ≥36 months of age. The vaccine should not be injected into the gluteal area or areas where there may be a major nerve trunk.

Do not administer this product intravenously, intradermally, or subcutaneously.

Fluzone Quadrivalent should not be combined through reconstitution or mixed with any other vaccine.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.